Platinum-resistant ovarian cancer

1 paper

In silico1

Trial sponsors

Genmab
Company3 trialsPhase 31,618 people
CSPC Megalith Biopharmaceutical
Company1 trialPhase 3460 people
Mural Oncology
Company1 trialPhase 3456 people
Aravive
Company1 trialPhase 3366 people
Genelux Corporation
Company1 trialPhase 3186 people
Cordgenics
Company1 trialPhase 3150 people
Sutro Biopharma
Company1 trialPhase 2/3600 people
Laekna
Company1 trialPhase 2150 people

Latest

1 in 12 months

GeroScience2 Jun

The role of cellular senescence in immune-metabolic features and prognosis of ovarian cancer: an integrated analysis based on single-cell sequencing and multi-omics data

Computational studyOvarian cancer